Brochure
14 Sep 2026

Integrated Biologics CDMO Services

PDF 2.0 MB

Prestige Biologics is a biologics-focused CDMO providing drug substance (DS) and drug product (DP) manufacturing services from technology transfer through commercial supply. Our capabilities include GMP manufacturing, analytical testing, stability studies, clinical trial packaging, and storage solutions, supported by a total manufacturing capacity of 154,000 L and integrated operations at a single site.

Content provided by our supplier

PRESTIGE BIOLOGICS

  • Country/Region:
    Korea, Republic Of
  • On CPHI since:
    2022
  • Certificates:
    3
  • Employees:
    250 - 499
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Drug delivery device Supplier/Manufacturer
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Packaging supplier/manufacturer
Primary activities
Analytical Services
Biopharmaceutical
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis

Other Content from PRESTIGE BIOLOGICS (1)

  • News Flexible CDMO/CMO Service by dynamics of each plant: Prestige Biologics

    Prestige Biologics operates state-of-the-art Drug Substance (DS) production facilities that effectively support both Upstream and Downstream processes. Our GMP facilities meet the most stringent global standards, contributing to the ecosystem of biopharmaceutical supply. Prestige Biologics offers customers production capabilities for monoclonal antibodies (mAb), bi-specific antibodies (bsAb), multi-antibodies, fusion antibodies, and recombinant proteins. We have accumulated extensive experience to ensure optimal production efficiency.

    Drawing on our experience in process development and commercial production of several #biosimilars and #biologics pharmaceuticals in 2,000 L Single-Use Bioreactors, we are committed to sharing our expertise with our customers.

    We hope to share our story of providing flexible and reliable Contract Manufacturing Organization (CMO) services for biopharmaceuticals at CPHI.